Dr. Oscar E. Streeter Jr., MD

Dr. Streeter practices at Summa Health System - Akron Campus in Akron, Ohio, part of General Catalyst.

Dr. Streeter's NPI, 1083764963, was assigned on January 11, 2007. Dr. Streeter graduated from Howard University College Of Medicine in 1982. Dr. Streeter holds California license G56948.

Dr. Streeter's primary practice is Summa Health System - Akron Campus, at 525 East Market Street, Akron, OH 44309 in Summit County. The practice phone is (330) 375-3000.

Dr. Streeter's primary practice is Summa Health System - Akron Campus in Akron, Ohio, part of General Catalyst. The medical group on file is Summa Health Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Streeter practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Streeter's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Streeter is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Streeter's licenses on file in 5 states: California, Ohio, Arizona, Nevada and District of Columbia.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Streeter treats.

CMS data shows 785 Medicare services from Dr. Streeter across 7 procedure codes in 2024, for 140 Medicare patients. Medicare paid $42,835 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 140 Medicare patients who saw Dr. Streeter in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have cancer, and 72% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Streeter's median patient age at 74, with 46% women.

In 2024, Dr. Streeter wrote 131 Medicare Part D claims for 62 patients. 84% of them were for generic drugs. CMS names the drug for 97 of them, across 5 drugs with 11 or more claims each, at $993 in total drug cost. In 2023, CMS named 32 claims across 1 drug.

Dr. Streeter accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 18 papers to Dr. Streeter, published from 2010 to 2021. The most frequent topics are Brachytherapy, Breast Neoplasms and Radiotherapy Dosage. Dr. Streeter has published most often in Int J Radiat Oncol Biol Phys. Dr. Streeter's most frequent co-authors are Martin E. Keisch, MD, Coral A. Quiet, MD and Pamela Renee Benitez, MD.

Dmand AI links Dr. Streeter to 1 clinical trial. Conditions studied include Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 52 general payments to Dr. Streeter from 21 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 66% of the total. Boston Scientific Corporation paid the most, $872.

Dmand AI lists 3 awards for Dr. Streeter, most recently SuperDoctors Los Angeles in 2015.

Dr. Streeter graduated from Howard University College Of Medicine in 1982. Dr. Streeter is a member of AOA and ASCO.

Dr. Streeter is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.